Clinical Trial Update: Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review

View source ↗

Summary

Enrollment by invitation is underway for a head-to-head evaluation of the COSMO AI system vs. pathologist review. The study includes brain cancer, lung cancer, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Lung Cancer
• Renal Cancer

Snippet

Sponsor: Harvard Medical School (HMS and HSDM) | Conditions: Brain Cancer, Lung Cancer (Diagnosis) | Status: ENROLLING_BY_INVITATION